Internal Med

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Schlager O et al. - Hs-CRP predicts cardiovascular and renal outcome in PAD patients irrespective of the presence of RAS. Patients with hs-CRP levels above 0.88mg/dL were at particularly high risk for MACE.

Today in Nephrology/Urology...keeping you current

Randomized, Double-blind, Placebo-controlled Trial of Flexible-dose Fesoterodine in Subjects With Overactive Bladder
Urology, 12/08/09

Sarcoidosis Presenting as an Epididymal Mass
Journal of the American Osteopathic Association, 12/08/09

The association of renal impairment with all-cause and cardiovascular disease mortality
Nephrology Dialysis Transplantation, 12/08/09